Active Ingredient: Dactinomycin 500mcg
Dosage Form: Lyophilised powder for solution for injection
- As a single agent or as a part of combination chemotherapy and/or multi-modality treatment regimen for Wilms’ tumor, childhood rhabdomyosarcoma, Ewing’s sarcoma, and metastatic nonseminomatous testicular cancer, gestational trophoblastic neoplasia.
- Treatment of locally recurrent or locoregionally metastatic melanoma in combination with Mephalan
Packaging: Box of 1 vials
Manufacturer: Baxter Oncology GmbH – Germany
MAH: Orphan Europe SARL – France